Global Human Chorionic Gonadotropin (HCG) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 154853
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

Scope of the Report:

This report focuses on the Human Chorionic Gonadotropin (HCG) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

The worldwide market for Human Chorionic Gonadotropin (HCG) is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 560 million US$ in 2023, from 390 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

EMD Serono, Inc

Ferring B.V

Merck & Co., Inc

Bristol Myers Squibb Company

Fresenius Kabi AG, LLC

Scrippslabs

Leebio

Kamiya Biomedical Company

Sanzyme

Cigna

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Natural Source Extraction

Recombinant DNA Technology

Market Segment by Applications, can be divided into

Female Infertility Treatment

Oligospermic Treatment

Cryptorchidism Treatment

Others

There are 15 Chapters to deeply display the global Human Chorionic Gonadotropin (HCG) market.

Chapter 1, to describe Human Chorionic Gonadotropin (HCG) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Chorionic Gonadotropin (HCG), with sales, revenue, and price of Human Chorionic Gonadotropin (HCG), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Chorionic Gonadotropin (HCG), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Chorionic Gonadotropin (HCG) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Chorionic Gonadotropin (HCG) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Human Chorionic Gonadotropin (HCG) Introduction

1.2 Market Analysis by Type

1.2.1 Natural Source Extraction

1.2.2 Recombinant DNA Technology

1.3 Market Analysis by Applications

1.3.1 Female Infertility Treatment

1.3.2 Oligospermic Treatment

1.3.3 Cryptorchidism Treatment

1.3.4 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 EMD Serono, Inc

2.1.1 Business Overview

2.1.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Ferring B.V

2.2.1 Business Overview

2.2.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Merck & Co., Inc

2.3.1 Business Overview

2.3.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bristol Myers Squibb Company

2.4.1 Business Overview

2.4.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Fresenius Kabi AG, LLC

2.5.1 Business Overview

2.5.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Scrippslabs

2.6.1 Business Overview

2.6.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Leebio

2.7.1 Business Overview

2.7.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Kamiya Biomedical Company

2.8.1 Business Overview

2.8.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanzyme

2.9.1 Business Overview

2.9.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Cigna

2.10.1 Business Overview

2.10.2 Human Chorionic Gonadotropin (HCG) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share in 2017

3.3.2 Top 6 Human Chorionic Gonadotropin (HCG) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Chorionic Gonadotropin (HCG) Market Analysis by Regions

4.1 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Regions

4.1.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

4.3 Europe Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

4.5 South America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

5 North America Human Chorionic Gonadotropin (HCG) by Countries

5.1 North America Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Countries

5.1.1 North America Human Chorionic Gonadotropin (HCG) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

5.3 Canada Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

5.4 Mexico Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

6 Europe Human Chorionic Gonadotropin (HCG) by Countries

6.1 Europe Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

6.3 UK Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

6.4 France Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

6.5 Russia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

6.6 Italy Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Chorionic Gonadotropin (HCG) by Countries

7.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Countries (2013-2018)

7.2 China Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

7.3 Japan Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

7.4 Korea Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

7.5 India Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

8 South America Human Chorionic Gonadotropin (HCG) by Countries

8.1 South America Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Countries

8.1.1 South America Human Chorionic Gonadotropin (HCG) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

8.3 Argentina Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

8.4 Colombia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Countries

9.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

9.3 UAE Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

9.4 Egypt Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

9.6 South Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2013-2018)

10 Global Human Chorionic Gonadotropin (HCG) Market Segment by Type

10.1 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Chorionic Gonadotropin (HCG) Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue and Market Share by Type (2013-2018)

10.2 Natural Source Extraction Sales Growth and Price

10.2.1 Global Natural Source Extraction Sales Growth (2013-2018)

10.2.2 Global Natural Source Extraction Price (2013-2018)

10.3 Recombinant DNA Technology Sales Growth and Price

10.3.1 Global Recombinant DNA Technology Sales Growth (2013-2018)

10.3.2 Global Recombinant DNA Technology Price (2013-2018)

11 Global Human Chorionic Gonadotropin (HCG) Market Segment by Application

11.1 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2013-2018)

11.2 Female Infertility Treatment Sales Growth (2013-2018)

11.3 Oligospermic Treatment Sales Growth (2013-2018)

11.4 Cryptorchidism Treatment Sales Growth (2013-2018)

11.5 Others Sales Growth (2013-2018)

12 Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.1 Global Human Chorionic Gonadotropin (HCG) Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Chorionic Gonadotropin (HCG) Market Forecast by Regions (2018-2023)

12.2.1 North America Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.2.2 Europe Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.2.4 South America Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Forecast (2018-2023)

12.3 Human Chorionic Gonadotropin (HCG) Market Forecast by Type (2018-2023)

12.3.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type (2018-2023)

12.3.2 Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Type (2018-2023)

12.4 Human Chorionic Gonadotropin (HCG) Market Forecast by Application (2018-2023)

12.4.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application (2018-2023)

12.4.2 Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Human Chorionic Gonadotropin (HCG) Picture

Table Product Specifications of Human Chorionic Gonadotropin (HCG)

Figure Global Sales Market Share of Human Chorionic Gon

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery